| Theme | The appropriate management for CKD-MBD in the elderly patients | |
|---|---|---|
| Title | How to use the biomarker in diagnosis and evaluation of CKD-MBD | |
| Publish Date | 2016/06 | |
| Author | Akiko Soda | Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine |
| Author | Sahoko Kamejima | Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine |
| Author | Ichiro Ohkido | Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of Medicine |
| [ Summary ] | Aging has become a serious problem in Japan, and it has increased the proportion of the elderly with renal dysfunction. In clinical practice, the opportunity to see a case involving both bone and mineral metabolism disorders due to renal dysfunction and osteoporosis due to aging is increasing. However, clear targets for therapeutic intervention for these disorders in the elderly have not been established. Therapeutic targets based on an individual's condition have yet to be determined. New biomarkers such as FGF23 and Klotho have been reported and elucidation of the clinical significance of these markers is expected. | |